Role of peoxisome proliferator activator receptor γ on blood retinal barrier breakdown

PPAR Research

Volumn , Issue , 2008, Pages

  Yanagi, Yasuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOGENESIS; ANGIOGENESIS; BLOOD RETINA BARRIER; CELL ADHESION; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; LEUKOCYTE; LEUKOSTASIS; PROTEIN FUNCTION; REVIEW;

EID: 41149143097     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/679237     Document Type: Review

References (22)

1. S. E. Moss R. Klein B. E. Klein The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105 6 1998 998 1003
2. J.-F. Angers angers@dms.umontreal.ca A. Biswas atanu@isical.ac.in A Bayesian analysis of the 4-year follow-up data of the Wilconsin epidemiologic study of diabetic retinopathy. Statistics in Medicine 23 4 2004 601 615
3. G. M. Comer T. A. Ciulla thomasciulla@yahoo.com Pharmacotherapy for diabetic retinopathy. Current Opinion in Ophthalmology 15 6 2004 508 518
4. R. Grigorian N. Bhagat P. Lanzetta A. Tutela M. Zarbin zarbin@umdnj.edu Pars plana vitrectomy for refractory diabetic macular edema. Seminars in Ophthalmology 18 3 2003 116 120
5. E. T. Cunningham Jr. barrett.katz@eyetech.com A. P. Adamis M. Altaweel A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112 10 2005 1747 1757
6. C. Haritoglou Haritoglou@med.uni-muenchen.de D. Kook A. Neubauer Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26 9 2006 999 1005
7. A. M. Joussen Joussen.A@aol.com V. Poulaki M. L. Le A central role for inflammation in the pathogenesis of diabetic retinopathy. The FASEB Journal 18 12 2004 1450 1452
8. K. Miyamoto Y. Ogura Pathogenetic potential of leukocytes in diabetic retinopathy. Seminars in Ophthalmology 14 4 1999 233 239
9. D. S. McLeod D. J. Lefer C. Merges G. A. Lutty Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. American Journal of Pathology 147 3 1995 642 653
10. H. Funatsu tfunatsu@nifty.com H. Yamashita T. Ikeda T. Mimura S. Eguchi S. Hori Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 110 9 2003 1690 1696
11. K. Miyamoto S. Khosrof S.-E. Bursell Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proceedings of the National Academy of Sciences of the United States of America 96 19 1999 10836 10841
12. A. M. Joussen V. Poulaki W. Qin Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. American Journal of Pathology 160 2 2002 501 509
13. K. Miyamoto S. Khosrof S.-E. Bursell Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). American Journal of Pathology 156 5 2000 1733 1739
14. A. M. Joussen T. Murata A. Tsujikawa B. Kirchhof S.-E. Bursell A. P. Adamis Leukocyte-mediated endothelial cell injury and death in the diabetic retina. American Journal of Pathology 158 1 2001 147 152
15. A. Nakajima K. Wada H. Miki Endogenous PPAR γ mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120 2 2001 460 469
16. W. Chen W. J. Esselman D. B. Jump J. V. Busik busik@msu.edu Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Investigative Ophthalmology & Visual Science 46 11 2005 4342 4347
17. A. M. Joussen V. Poulaki N. Mitsiades Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression. The FASEB Journal 16 3 2002 438 440
18. E. D. Rosen B. M. Spiegelman bruce_spiegelman@dfci.harvard.edu PPAR γ : a nuclear regulator of metabolism, differentiation, and cell growth. Journal of Biological Chemistry 276 41 2001 37731 37734
19. M. Okada S. F. Yan D. J. Pinsky djp5@columbia.edu Peroxisome proliferator-activated receptor-γ ( PPAR γ) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. The FASEB Journal 16 14 2002 1861 1868
20. V. Pasceri H. D. Wu J. T. Willerson E. T. Yeh Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators. Circulation 101 3 2000 235 238
21. C. Wang M. Fu M. D'Amico Inhibition of cellular proliferation through IκB kinase-independent and peroxisome proliferator-activated receptor γ-dependent repression of cyclin D1. Molecular and Cellular Biology 21 9 2001 3057 3070
22. K. Muranaka Y. Yanagi yanagi-tky@umin.ac.jp Y. Tamaki Effects of peroxisome proliferator-activated receptor γ and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Investigative Ophthalmology & Visual Science 47 10 2006 4547 4552